Comparison of Sales Expense Ratio and R&D Expense Ratio of Leading Pharmaceutical Enterprises at Home and Abroad
Objective To compare the sales expenses and R&D expense of domestic and foreign head pharmaceutical enterprises.Methods The revenue,sales expenses and research and development expenses of European,American,Japanese,Chinese leading chemical pharmaceutical and Chinese traditional medicine pharmaceutical enterprises were collected through company annual reports,and the sales expense ratio and research and development expense ratio were calculated and compared.Results The average sales expense ratio of European and American enterprises,Japanese enterprises,Chinese chemical pharmaceutical enterprises and Chinese traditional Chinese medicine enterprises in recent 3 years were(25.1±1.6)%,(33.5±2.5)%,(40.9±2.5)%,(41.9±1.1)%,respectively.In recent 3 years,the average R&D expense rate was(19.3±1.3)%,(19.7±0.9)%,(12.3±1.2)%,(4.8±0.6)%,respectively.Conclusion The sales expense ratio of Chinese leading pharmaceutical enterprises is significantly higher than that of European,American and Japanese enterprises,while the R&D expense ratio is significantly lower than that of European,American and Japanese enterprises.It is suggested to adopt a variety of measures to establish a long-term drug price formation mechanism,balance the interests of all parties,and promote the sales cost of Chinese pharmaceutical enterprises to return to a reasonable level.
Domestic and foreign leading pharmaceutical enterprisesSales expense ratioR&d expense rateDrug promotion modelPolicy suggestion
国家科技期刊平台
NSTL
万方数据
